Philippe Moreau

4 ta ish

Dana-Farber Cancer Institute

1. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

   Nikhil C. Munshi, Larry D. Anderson, Nina Shah +25

   Maqola20217 iqtibos

   ABIABI:AkademIndex/2026.other.296878

2. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

   Michèle Cavo, Evangelos Terpos, Cristina Nanni +25

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.466312

3. International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

   Hervé Avet‐Loiseau, Faith E. Davies, Mehmet Samur +43

   Maqola20252 iqtibos

   ABIABI:AkademIndex/2026.other.480252

4. FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma

   Pierre‐Yves Salaün, Thomas Gastinne, Éric Frampas +3

   MaqolaOAOchiq kirish20080 iqtibos

   ABIABI:AkademIndex/2008.article.000551